Covid-19 vaccine: FDA could consider authorization before Phase 3 trials are over, Financial Times reports - 2020-08-30
(CNN) In an interview with the Financial Times, US Food and Drug Administration Commissioner Dr. Stephen Hahn said the agency could consider emergency use authorization or approval for a Covid-19 vaccine before Phase 3 trials are complete.
"It is up to the sponsor [vaccine developer] to apply for authorisation or approval, and we make an adjudication of their application," Hahn told the Financial Times . "If they do that before the end of Phase Three, we may find that appropriate. We may find that inappropriate, we will make a determination."
Hahn noted that an EUA is not the same as FDA approval.